Drug intelligence / Profile preview

norepinephrine + crystalloid

Development stage
Unknown
Lead developer
General Hospital of Ningxia Medical University
Modality
Small Molecules
Administration
Intravenous
01

Overview

This intervention refers to the co-administration of intravenous **crystalloid** fluids (such as normal saline or lactated Ringer's solution) and a prophylactic infusion of **norepinephrine** to prevent hypotension following spinal anesthesia in patients undergoing cesarean section. The protocol, studied at the **General Hospital of Ningxia Medical University** (NCT05690334), evaluates how varying volumes of crystalloid coload (0, 5, or 10 mL/kg) influence the 90% effective dose (ED90) of norepinephrine. Norepinephrine acts as a potent alpha-adrenergic agonist to maintain systemic vascular resistance, while crystalloids provide immediate intravascular volume expansion to counteract the vasodilation induced by spinal anesthesia.

Other names
crystalloid coloadnorepinephrine infusioncrystalloid-General Hospital of Ningxia Medical University-post-spinal anesthesia hypotension
02

Targets

ADRA1A (α1A)ADRA2A (α2A)ADRB1 (β1)

Beyond the preview

Go deeper on norepinephrine + crystalloid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on norepinephrine + crystalloid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call